Fidelity Investments’s Cerevel Therapeutics Holdings, Inc. Common Stock CERE Stock Holding History
Bought
Maintained
Sold
| Quarter | Market Value | Status | Shares |
Change in Stake | Trade Value | Portfolio Weight | Portfolio Position | |
|---|---|---|---|---|---|---|---|---|
|
2024
Q3 | – | Sell |
|
|||||
|
2024
Q2 | $200K | Sell |
|
|||||
|
2024
Q1 | $75.8M | Sell |
|
|||||
|
2023
Q4 | $411M | Sell |
|
|||||
|
2023
Q3 | $516M | Buy |
|
|||||
|
2023
Q2 | $747M | Buy |
|
|||||
|
2023
Q1 | $572M | Buy |
|
|||||
|
2022
Q4 | $739M | Buy |
|
|||||
|
2022
Q3 | $659M | Buy |
|
|||||
|
2022
Q2 | $588M | Buy |
|
|||||
|
2022
Q1 | $777M | Buy |
|
|||||
|
2021
Q4 | $633M | Buy |
|
|||||
|
2021
Q3 | $555M | Buy |
|
|||||
|
2021
Q2 | $226M | Buy |
|
|||||
|
2021
Q1 | $70.2M | Buy |
|
|||||
|
2020
Q4 | $71.5M | Buy |
|